FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to a compound of formula II for complexing metal isotopes: where X denotes a chelating agent, selected from DOTK (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), DOTKGC (dodeca-1-glutaric acid-1,4,7,10-tetraamine triacetic acid), DOTKM (1,4,7,10-tetrakis- (carbamoylmethyl)-1,4,7,10-tetraazacyclododecane) and other derivatives of DOTK, NOTK (nona-1,4,7-triamine triacetic acid) and derivatives thereof, such as NOTKGK (1,4,7-triazacyclononane, 1-(glutaric acid), 4,7-acetic acid), AAZTK (6-amino-6-methylperhydro-1,4-diazepin-N,N,N',N'-tetraacetic acid), and R3 denotes ; as well as to pharmaceutical agents, consisting of a compound of formula II and forming a metal isotope complex with it, to a method for producing said agent and use thereof in diagnostic methods, in methods of treating bone diseases and as additives in artificial bone substance, in bone cement or in bone implants.
EFFECT: group of inventions provides creating an agent possessing high and selective accumulation in bones and bone tumors.
25 cl, 4 tbl, 9 ex, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPLEX COMPOUNDS CONTAINING RADIONUCLIDE Th, AS WELL AS BISPHOSPHONATE FRAGMENT, METHODS FOR THEIR PRODUCTION, AS WELL AS POTENTIAL USE AS ACTIVE SUBSTANCE IN COMPOSITION OF OSTEOTROPIC RADIOPHARMACEUTICAL DRUG | 2020 |
|
RU2767567C1 |
COMPLEX CONTAINING A PSMA-TARGETING COMPOUND BOUND TO A LEAD OR THORIUM RADIONUCLIDE | 2018 |
|
RU2795398C2 |
SOMASTATINIC PEPTIDES, RADIOPHARMACEUTICAL AGENT, METHOD OF TREATING TUMORS, AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2156774C2 |
RADIOPHARMACEUTICAL SOLUTIONS WITH PREFERRED PROPERTIES | 2016 |
|
RU2741794C2 |
PARAMINOHYPURIC ACID (PAH) AS A KIDNEY PROTECTOR | 2020 |
|
RU2804349C2 |
PSMA-TARGET COMPOUND AND ITS COMPLEX WITH RADIONUCLIDES FOR THERANOSTICS OF TUMOR EXPRESSING PSMA | 2022 |
|
RU2803734C1 |
COMPOUND FOR DIAGNOSING TUMOURS EXPRESSING PSMA AND COMPOSITION BASED THEREON | 2019 |
|
RU2730507C1 |
SOMATOSTATIN ANALOGUES | 2001 |
|
RU2287533C2 |
OSTEOTROPIC RADIOPHARMACEUTICALS FOR PET IMAGING | 2014 |
|
RU2614235C2 |
METHOD OF OBTAINING PSMA-TARGET COMPOUND COMPLEX BASED ON UREA Lu-PS-161 AND COMPLEX | 2023 |
|
RU2808636C1 |
Authors
Dates
2021-02-09—Published
2015-10-16—Filed